CN104436060A - 一种护理治疗胆管细胞癌的中药配方及其制备方法 - Google Patents
一种护理治疗胆管细胞癌的中药配方及其制备方法 Download PDFInfo
- Publication number
- CN104436060A CN104436060A CN201410768436.5A CN201410768436A CN104436060A CN 104436060 A CN104436060 A CN 104436060A CN 201410768436 A CN201410768436 A CN 201410768436A CN 104436060 A CN104436060 A CN 104436060A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- chinese medicine
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 125
- 208000006990 cholangiocarcinoma Diseases 0.000 title claims abstract description 31
- 230000000474 nursing effect Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 241000746375 Andrographis Species 0.000 claims abstract description 9
- 240000007926 Ocimum gratissimum Species 0.000 claims abstract description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 9
- 235000008434 ginseng Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 241000208340 Araliaceae Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241001250596 Pleione Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 238000001802 infusion Methods 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 16
- 230000036039 immunity Effects 0.000 abstract description 8
- 238000001467 acupuncture Methods 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 210000003205 muscle Anatomy 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000031023 Amana edulis Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241001553700 Euphorbia lathyris Species 0.000 abstract 1
- 241000865486 Knoxia Species 0.000 abstract 1
- 235000004066 Ocimum gratissimum Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 240000009235 Rubia cordifolia Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 abstract 1
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 210000002435 tendon Anatomy 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 36
- 210000004369 blood Anatomy 0.000 description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 24
- 210000000214 mouth Anatomy 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 22
- 201000010099 disease Diseases 0.000 description 22
- 210000002683 foot Anatomy 0.000 description 19
- 210000004072 lung Anatomy 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 19
- 238000011282 treatment Methods 0.000 description 18
- 206010028980 Neoplasm Diseases 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 14
- 230000008961 swelling Effects 0.000 description 13
- 206010007247 Carbuncle Diseases 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 12
- 201000000736 Amenorrhea Diseases 0.000 description 11
- 206010001928 Amenorrhoea Diseases 0.000 description 11
- 210000001015 abdomen Anatomy 0.000 description 11
- 231100000540 amenorrhea Toxicity 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 208000026435 phlegm Diseases 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 206010010904 Convulsion Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 201000006549 dyspepsia Diseases 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 208000034507 Haematemesis Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 210000003371 toe Anatomy 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000006877 Insect Bites and Stings Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 210000001255 hallux Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010008531 Chills Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010053155 Epigastric discomfort Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000124079 Mylabris Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N pentadecane Chemical compound CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 210000000453 second toe Anatomy 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000593357 Austroderia fulvida Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000015163 Biliary Tract disease Diseases 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 241001327965 Clonorchis sinensis Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019754 Hepatitis cholestatic Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000008277 Immersion Foot Diseases 0.000 description 1
- 206010049949 Intercostal neuralgia Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027295 Menometrorrhagia Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 208000001089 Multiple system atrophy Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010031127 Orthostatic hypotension Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000007660 Residual Neoplasm Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010044584 Trench foot Diseases 0.000 description 1
- 206010050283 Tumour ulceration Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003097 anti-respiratory effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- -1 antibacterial Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000037512 bile duct cyst Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001173 choledochal cyst Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 231100000838 cholestatic hepatitis Toxicity 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 210000003459 common hepatic duct Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000002603 extrahepatic bile duct Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000004744 fore-foot Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000001809 melena Anatomy 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001226 toe joint Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Physiology (AREA)
- Insects & Arthropods (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药技术领域,特别涉及一种护理治疗胆管细胞癌的中药配方及其制备方法。中药配方由内服药和外用药组成,其中内服药由以下重量份数的中药原料配制而成:人参10-15份,青黛5-8份,牛黄2-4份,菊花2-4份,柴胡10-15份,蚤休10-15份,茯苓10-15份,赤芍4-10份,茜草10-15份,当归10-15份,黄芩2-4份,莪术10-15份,瓜蒌10-15份,鳖甲3-8份,虎杖3-8份;其中外用药由以下重量份数的中药原料配制而成:败酱草5-8份,山慈菇3-5份,五倍子10-15份,红大戟15-20份,穿心莲3-5份,千金子10-15份,三七5-10份,冰片5-10份,丁香罗勒6-10份,陈皮10-15份。通过中药泡脚外用,药物刺激肝经穴位,舒筋通络,配合内服中药的养阴护肝、化瘀散结之效,调理肝脾代谢,增强免疫力,挽救病人生命。
Description
技术领域
本发明属于中药技术领域,特别涉及一种护理治疗胆管细胞癌的中药配方及其制备方法。
背景技术
胆管癌是指原发于左右肝管汇合部至胆总管下端的肝外胆管恶性肿瘤。胆管癌的病因尚不清楚,与其发病可能有关的因素有:溃疡性结肠炎、胆结石、中华分枝睾吸虫感染、胆总管囊肿等,这些因素都能增加胆管癌发病的危险性。临床表现主要为伴有上腹部不适的进行性黄疸、食欲不振、消瘦、瘙痒等。如肿瘤破溃出血,可有黑便或大便潜血试验阳性、贫血等表现。近十年来胆管癌发病率逐年升高,在个别高发地区十年来胆管癌发病率甚至已经翻番。胆管癌的治疗方法有多种,其中常用的方法有手术、放化疗,手术固然能切除癌肿,但还有残癌、或区域***转移、或血管中癌栓会影响病人健康。
胆管癌的治疗方法要根据患者的具体情况来决定。一般来说,早期胆管癌多采用手术切除,配合放化疗和中药辅助治疗,中晚期患者多不采用手术治疗,以中药扶正祛邪的治疗原则为主,提倡带瘤生存。而且对于不适合手术,也无法承受放化疗的患者,中药的综合治疗是很好的方法。
中医认为,胆管癌多因肝郁气滞,饮食不节,湿热壅阻,日久化火蕴蒸于内,痹阻不通而成胆道症块,其病变部位涉及肝、胆、脾胃,主要病变在肝胆。另外,中医治疗胆管癌注意考虑全身的整体情况与局部瘤体的关系,在疾病早中期即身体邪盛正未衰时,以攻为主辨证治疗,清热解毒,活血化瘀、软坚散结、以毒攻毒,抑制肿瘤的生长;在疾病中晚期,正气已损,邪气嚣张,扶正培本治疗,寓攻于补,提高免疫力,保护机体正常机能,改善病人临床症状,减轻患者疼痛,提高患者生存质量。
目前还没有一种中药能够有效的护理和治疗胆管细胞癌患者。
发明内容
本发明根据现有技术的不足,提供一种通过中药内服外药相配合,能够抑制肿瘤繁殖,调理肝脾代谢,增强免疫力护理治疗胆管细胞癌的中药配方及其制备方法。
本发明提供一种护理治疗胆管细胞癌的中药配方,由内服药和外用药组成,其中内服药由以下重量份数的中药原料配制而成:人参10-15份,青黛5-8份,牛黄2-4份,菊花2-4份,柴胡10-15份,蚤休10-15份,茯苓10-15份,赤芍4-10份,茜草10-15份,当归10-15份,黄芩2-4份,莪术10-15份,瓜蒌10-15份,鳖甲3-8份,虎杖3-8份;
其中外用药由以下重量份数的中药原料配制而成:败酱草5-8份,山慈菇3-5份,五倍子10-15份,红大戟15-20份,穿心莲3-5份,千金子10-15份,三七5-10份,冰片5-10份,丁香罗勒6-10份,陈皮10-15份。
一种护理治疗胆管细胞癌的中药配方,内服药优选为由以下重量份数的中药原料配制而成:人参13份,青黛6份,牛黄3份,菊花3份,柴胡13份,蚤休12份,茯苓13份,赤芍6份,茜草12份,当归12份,黄芩3份,莪术13份,瓜蒌13份,鳖甲6份,虎杖6份。
一种护理治疗胆管细胞癌的中药配方,外用药优选为由以下重量份数的中药原料配制而成:败酱草6份,山慈菇4份,五倍子12份,红大戟17份,穿心莲4份,千金子14份,三七6份,冰片7份,丁香罗勒8份,陈皮14份。
一种制备护理治疗胆管细胞癌的中药配方的方法,由以下步骤组成:1)内服药按上述重量份称取中药原料,加入冷水,没过药材4-6cm,浸泡1个小时;然后进行煎煮,先用武火煮开,煮开后转为文火熬煮35-40min;煮好后,滤出药汁作为头煎;将药渣重复上述步骤煎煮,煮好后,将两次煎煮的药汁合并即可;2)外用药按上述重量份称取中药原料重复进行步骤一,取出药液倒入泡脚盆中,向泡脚盆内加入温度为35-45℃的热水,脚伸入泡脚盆中浸泡15-20分钟即可。
使用方法,每晚睡前服用一副内服药,并使用一副外用药泡脚。10天一个疗程。
药理分析:
人参:味甘、微苦,性平。归脾、肺、心经。有良好的抗衰老、抗疲劳、提高人体的免疫力、调节神经***和兴奋造血***功能等作用。改善中老年人的微循环,提高记忆、学习能力。常用于治疗各种类型的老年痴呆,尤其适用于心脾气血两虚症,或兼肺气亏虚、神疲乏力、虚咳喘促、自汗暴脱等症。发热感冒、咳嗽痰多、心肝火旺、湿热蕴阻、食滞不化者慎用。
青黛:性味咸寒,归肝、肺、胃经。有清热解毒、凉血散肿、清肝泻火、定惊等作用。主治温病热盛,斑疹,吐血,咯血,咽痛,口疮,小儿惊痫,疮肿,丹毒,湿疹,痤痈,痄腮,蛇虫咬伤等。现代药理研究显示,青黛有抗肿瘤、抗细菌和皮肤真菌、增强免疫、治疗溃疡、保肝等作用。
牛黄:味甘,性凉。归心、肝经。能够清心,豁痰,开窍,凉肝,息风,解毒。用于热病神昏,中风痰迷,惊痫抽搐,癫痫发狂,咽喉肿痛,口舌生疮,痈肿疔疮。
菊花:味甘、苦,性微寒。归肺、肝经。疏风清热,平肝明目,解毒消肿,疏风、清热、明目、解毒之功效,主要治疗头痛、眩晕、目赤、心胸烦热、疔疮、肿毒等症。
柴胡:味苦、平,无毒。主心腹肠胃中结气,饮食积聚,寒热邪气,推陈致新。久服轻身、明目、益精。清虚热中药,用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱落、***。
蚤休:味苦辛,性寒,入心、肝经。能够清热解毒,平喘止咳,熄风定惊,消肿止血。主治痈肿,疔疮,瘰疬,喉痹,慢性气管炎,小儿惊风抽搐,蛇虫咬伤,妇女经血不调,跌打损伤。
茯苓:味甘、淡,性平。归心、肺、脾、肾经。主治利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。具有抗氧化,防衰老,增加免疫力,提高大脑细胞活性的作用。茯苓有较强的利尿作用,可治疗肾炎、心衰水肿。另外还有镇静作用,对神经衰弱有效。味淡性平,善益气养血,宁心安神,败毒抗癌;药性平和,利湿而不伤正气,所含茯苓酸具有增强免疫力、抗肿瘤以及镇静、降血糖等的作用;可松弛消化道平滑肌,抑制胃酸分泌,防止肝细胞坏死,抗菌等功效。
赤芍:味苦,性微寒;归肝经;功能清热凉血,活血祛瘀。主治温毒发斑,吐血衄血,肠风下血,目赤肿痛,痈肿疮疡,闭经,痛经,崩带淋浊,瘀滞胁痛,疝瘕积聚,跌扑损伤。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。现代药理学研究证明,赤芍有解热、抗菌、解痉、镇痛作用,并能抑制体液和细胞免疫反应,临床验证表明,赤芍治疗急性胆汁淤积型肝炎、慢活型重度黄疸肝炎有明显的顿挫黄疸和利胆作用。
茜草:味苦,性寒。归肝经。能够凉血活血,祛瘀,通经。用于吐血、衄血、崩漏下血、外伤出血、经闭瘀阻、关节痹痛、跌扑肿痛。凉血止血,活血祛瘀:本品止血而不留瘀,用于热证出血、经闭腹痛、跌打损伤。配乌贼骨止血力更强。有止血抗癌和抵抗心肌梗死的作用。并能镇咳、解痉,并能调节人体代谢,有利于能量代谢和氧力调节,能够抑制皮肤组织***通透性,并能降低尿钙水平,对多重致病菌有抑制作用。
当归:味甘、辛,性温。归肝、心、脾经。补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,***,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。
黄芩:味苦,性寒。归肺、胆、脾、大肠、小肠经。有清热燥湿,凉血安胎,解毒功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。
莪术:味辛、苦,性温。归肝、脾经。能够行气破血,消积止痛。用于燀瘕痞块,瘀血经闭,食积胀痛;早期***。
瓜蒌:性寒,味甘,微苦。归肺、胃、大肠经。主治:清热涤痰,宽胸散结,润燥滑肠。用于肺热咳嗽,痰浊黄稠,胸痹心痛,结胸痞满,乳痈,肺痈,肠痈肿痛,大便秘结。果实含三萜皂甙、有机酸、树脂、糖类和色素。果实中所含蛋白质与其块根“天花粉”中所含蛋白质不同,无中期引产作用。瓜蒌皮含少量挥发油。其中酸性部分有壬酸、癸酸、月桂酸、肉豆蔻酸、正十五烷酸、棕榈油酸、棕榈酸、亚油酸、亚麻酸、硬脂酸、歧链十四碳烷酸、三种十五歧链碳烷酸和歧链十六碳烷酸。以棕榈酸、亚油酸和亚麻酸的含量最高。
鳖甲:味咸,性微寒。归肝、肾经。养阴清热,平肝熄风,软坚散结。治劳热骨蒸,阴虚风动,劳疟疟母,症瘕痃癖,经闭经漏,小儿惊痫。
虎杖:微苦,微寒;归肝、胆、肺经;功能祛风,利湿,破瘀,通经;主治风湿筋骨疼痛,湿热黄疸,淋浊带下,妇女经闭,产后恶露不下,症瘕积聚,痔漏下血;跌扑损伤,烫伤,恶疮癣疾。抗心律失常和抗心肌失血;活血化瘀。
败酱草:味辛、苦,性凉。入胃、大肠、肝经。功能主治:清热解毒,消痈排脓,活血行瘀。用于肠痈、肺痈及疮痈肿毒,实热瘀滞所致的胸腹疼痛,产后瘀滞腹痛等症。
山慈菇:味甘,微辛,性寒;归肝,胃,肺经。能够清热解毒;消肿散结。主痈疽恶疮;瘰疬结核;咽痛喉痹;蛇、虫咬伤等。
五倍子:味酸、涩,性寒。归肺、大肠、肾经。主治敛肺降火,涩肠止泻,敛汗止血,收湿敛疮。用于肺虚久咳,肺热痰嗽,久泻久痢,盗汗,消渴,便血痔血,外伤出血,痈肿疮毒,皮肤湿烂。
红大戟:味苦,性寒。归肺、脾、肾经。能够解毒散结,主水肿胀满;痰饮喘急;痈疮肿毒。
穿心莲:味苦,性寒。归心、肺、大肠、膀胱经。清热解毒,凉血,消肿,燥湿。清热解毒,凉血消肿。治急性菌痢,胃肠炎,感冒,流脑,气管炎,肺炎,百日咳,肺结核,肺脓疡,胆囊炎,高血压,鼻衄,口咽肿痛,疮疖痈肿,水火烫伤,毒蛇咬伤。
千金子:味辛、性温。归肝、肾、大肠经。能够逐水消肿,破症杀虫。治水肿胀满,痰饮,宿滞,症瘕积聚;妇女经闭;疥癣疮毒,蛇咬,疣赘。具抗肿瘤作用。用于水肿、痰饮积滞胀满、二便不通、血瘀闭经。
三七:止血散瘀,消肿定痛,具有散瘀止血,消肿定痛之功效。主治咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌仆肿痛。
冰片:味苦辛,性微温,无毒。入心、肺经。通诸窍,散郁火,去翳明目,消肿止痛。治中风口噤,热病神昏,惊痫痰迷,气闭耳聋,喉痹,口疮,中耳炎,痈肿,痔疮,目亦翳膜,蛲虫病。冰片应用于局部对感觉神经的刺激很轻,而有某些止痛及温和的防腐作用,可用于神经痛。
丁香罗勒:味辛,性温。发汗解表,祛风利湿,散瘀止痛。用于风寒感冒,头痛,胃腹胀满,消化不良,胃痛,肠炎腹泻,跌打肿痛,风湿关节痛;外用治蛇咬伤,湿疹,皮炎。
陈皮:性味苦、辛,温;归肺、脾经;用于胸腹胀满等症。橘皮辛散通温,气味芳香,长于理气,能入脾肺,故既能行散肺气壅遏,又能行气宽中,用于肺气拥滞、胸膈痞满及脾胃气滞、脘腹胀满等症;用于湿阻中焦、脘腹痞胀、便溏泄泻,以及痰多咳嗽等症。橘皮苦温燥湿而能健脾行气,故常用于湿阻中焦、脘腹胀闷、便溏苔腻等症,可配伍苍术、厚朴同用陈皮。又善于燥湿化痰,为治湿痰壅肺、痰多咳嗽的常用要药,每与半夏、茯苓同用;用于脾虚饮食减少、消化不良,以及恶心呕吐等症。该品燥湿而能健脾开胃,适用于脾胃虚弱、饮食减少、消化不良、大便泄泻等症,因其既能健脾,又能理气,故往往用作补气药之佐使,可使补而不滞,有防止壅遏作胀作用。
其次,脚部肝经穴位包括大敦穴、太冲穴、行间穴和涌泉穴等,通过药物浸泡脚部,可以用药物刺激肝经穴位,舒筋通络,促进血液循环,促进皮肤血液循环,加快毒素排出,并能降低血液粘稠度。
大敦穴:位于大脚趾靠第二趾一侧的甲根边缘约2毫米处,具有调补肝肾作用,大敦穴的主治疾病为:目眩、腹痛、肌肋痛、冷感症。除此之外,自古以来亦被视为镇静及恢复神智的要穴。此穴位为人体足厥阴肝经上的主要穴道之一。
太冲穴:位于足背侧,第一、二趾跖骨连接部位中。以手指沿拇趾、次趾夹缝向上移压,压至能感觉到动脉映手,即是此穴。该穴名意指肝经的水湿风气在此向上冲行。本穴物质为行间穴传来的水湿风气,至本穴后因受热而胀散化为急风冲散穴外,故名。大冲名意与此穴同。
行间穴:位于第1、2趾间,趾蹼缘的后方赤白肉际处,为肝经俞穴,亦可调理肝气,行间穴位于足背侧,大拇趾、二趾合缝后方赤白肉分界处凹陷中,稍微靠大拇趾边缘。行间穴的主治病征为:宿醉不适、眼部疾病、腿抽筋、夜尿症、肝脏疾病、腹气上逆、肋间神经痛、月经过多、粘膜炎等。
涌泉穴:位于足前部凹陷处第2、3趾趾缝纹头端与足跟连线的前三分之一处,当用力弯曲脚趾时,足底前部出现的凹陷处就是涌泉穴。轻轻点按涌泉穴能通过经络传递作用,调节植物神经***,扩张血管、促进皮肤血液循环、加快毒素排出、降低血液粘稠度。
本发明的中药优点:通过中药泡脚外用,药物刺激肝经穴位,舒筋通络,促进血液循环,加快毒素排出,配合内服中药的养阴护肝、扶正祛邪、化瘀散结之效,又迅速止痛消肿,调理肝脾代谢,增强免疫力,减轻病人痛苦,挽救病人生命。
其中,对于胆管细胞癌患者来说,心里面的疾病远远大于身体上的,因为胆管细胞癌不是一个好治的病,病人天天在忍受着心灵的煎熬,那么医生和患者家人都应该帮助胆管细胞癌患者克服心理上的恐惧。具体护理的方式应注意以下几点:
1、当病人得知自己患有胆管细胞癌后,往往会出现轻生等过度悲观心态,医生和患者家属务必要做好相关的护理措施,尤其是要站在患者的角度思考问题。从心理上给病人安慰,胆管细胞癌病人急躁易怒,尤其家属应谅解忍让。
2、居住环境保持清洁舒适,房间对流通风。
3、基础护理应做到“六洁”(口腔、脸、头发、手足皮肤、***、床单位清洁)、“五防”(防褥疮、防直立性低血压、防呼吸***感染、防交叉感染、防***〕、“三无”(无粪、无坠床、无烫伤)、“一管理”(膳食管理)。
4、用药安全。遵医嘱按时、按量用药,做好药品保管。
5、健康教育,指导病人自我护理,纠正不良的生活***衡。
6、鼓励患者参与正常人的生活,参加轻松的工作,适量的学习,在工作和学习中重新确立自己的生存价值。
对于治疗效果来说,心情的良好是很重要的,注意保持良好的精神状态,这也是康复的重要条件。患者要注意克服自己的心理障碍,不要总是怀着恐惧心理,家属也要注意安慰及给予胆管细胞癌患者克服悲观恐惧心理的勇气和支持,使患者积极治疗疾病,树立打败病魔的决心,保持身心愉快,安心疗养。
在生活中,一定要注意合理的饮食习惯,注意不吃过于刺激的食物,要以清淡为主,多补充一些维生素的含量可以多吃新鲜蔬菜,还要补充适量的优质蛋白,高脂肪食物就要适可而止,要少许的摄入,禁食粗纤维食物,避免刺破曲张的食管静脉发生呕血。
收集100名胆管细胞癌患者,随机分为治疗组和对照组(服用某品牌斑蝥胶囊),每组50例;男50例,女50例;年龄35-75岁,平均55岁;病程最长1年,最短2周,平均约5个月。各组患者年龄症状构成无显著差异;治疗组患者采用本发明制剂进行治疗。
疗效判断:
显效:主要症状明显改善或消失,病灶缩小1/2以上,并持续1个月以上。
有效:主要症状有所改善或明显改善,病灶缩小1/4以上,并持续1个月以上。
无效:主要症状无改善或加重,病灶无变化或发展。
使用统计情况如下:
统计上述胆管细胞癌患者,1个月为一个疗程,使用2个疗程本发明的中药后,显效和有效共5例,占10%,对照组共1例,占2%;
6个疗程后治疗组的总体有效率为98%,对照组的总体有效率为26%;
并且,治疗组的患者5年及5年以上为32例,生存率占64%,而对照组仅有3人,生存率仅占6%,由此可见,本发明对胆管细胞癌有明显的治疗效果,并能尽可能延长病人生命。并且,斑蝥胶囊价格较高,不能够推广普及,但本发明所公开的中药制剂成本较低,普通民众能够接受,从而利于推广治疗。
附几例病例作进一步说明:
病例1:王某,男,50岁,患者上腹部不适,并且食欲不振、消瘦,检查可见肝肿大,后诊断为胆管细胞癌。因年岁已高身体吃不消,不敢做手术及化疗。服用本发明中药组合物制备的药剂进行保守治疗,使用1个月后疼痛消失,咳嗽、咳血获得控制,2个月后病情稳定,3个月后,患者精神恢复的很好,饮食正常,睡眠良好,生活可以自理。
病例2:郭某,男,57岁,患者出现无明显诱因的上腹部疼痛,肝区为主,无受凉,无饮酒,进食后,上腹部尤为不适。后来疼痛加重,遂就诊于当地医院,后确诊为胆管细胞癌。后转到我院治疗,采用本发明用药综合治疗后,病情稳定,无乏力、厌食、呕吐等症状,患者现能从事轻中度强度劳动,生活恢复正常。
具体实施方式
下面结合实施例对本发明进行进一步阐述,但本发明并不局限于具体实施例。
实施例1:
一种护理治疗胆管细胞癌的中药配方,由内服药和外用药组成,其中内服药由以下重量份数的中药原料配制而成:人参10份,青黛8份,牛黄2份,菊花4份,柴胡10份,蚤休15份,茯苓10份,赤芍10份,茜草10份,当归15份,黄芩2份,莪术15份,瓜蒌10份,鳖甲8份,虎杖3份。
其中外用药由以下重量份数的中药原料配制而成:败酱草8份,山慈菇3份,五倍子15份,红大戟15份,穿心莲5份,千金子10份,三七10份,冰片5份,丁香罗勒10份,陈皮10份。
实施例2:
一种护理治疗胆管细胞癌的中药配方,由内服药和外用药组成,其中内服药由以下重量份数的中药原料配制而成:人参15份,青黛5份,牛黄4份,菊花2份,柴胡15份,蚤休10份,茯苓15份,赤芍4份,茜草15份,当归10份,黄芩4份,莪术10份,瓜蒌15份,鳖甲3份,虎杖8份。
其中外用药由以下重量份数的中药原料配制而成:败酱草5份,山慈菇5份,五倍子10份,红大戟20份,穿心莲3份,千金子15份,三七5份,冰片10份,丁香罗勒6份,陈皮15份。
实施例3:
一种护理治疗胆管细胞癌的中药配方,由内服药和外用药组成,内服药为由以下重量份数的中药原料配制而成:人参13份,青黛6份,牛黄3份,菊花3份,柴胡13份,蚤休12份,茯苓13份,赤芍6份,茜草12份,当归12份,黄芩3份,莪术13份,瓜蒌13份,鳖甲6份,虎杖6份。
其中外用药为由以下重量份数的中药原料配制而成:败酱草6份,山慈菇4份,五倍子12份,红大戟17份,穿心莲4份,千金子14份,三七6份,冰片7份,丁香罗勒8份,陈皮14份。
实施例4:
一种制备护理治疗胆管细胞癌的中药配方的方法,由以下步骤组成:1)内服药按实施例1中的重量份称取中药原料,加入冷水,没过药材4cm,浸泡1个小时;然后进行煎煮,先用武火煮开,煮开后转为文火熬煮40min;煮好后,滤出药汁作为头煎;将药渣重复上述步骤煎煮,煮好后,将两次煎煮的药汁合并即可;2)外用药按实施例1中的重量份称取中药原料重复进行步骤一,取出药液倒入泡脚盆中,向泡脚盆内加入温度为35℃的热水,脚伸入泡脚盆中浸泡20分钟即可。
实施例5:
一种制备护理治疗胆管细胞癌的中药配方的方法,由以下步骤组成:1)内服药按实施例2中的重量份称取中药原料,加入冷水,没过药材6cm,浸泡1个小时;然后进行煎煮,先用武火煮开,煮开后转为文火熬煮35min;煮好后,滤出药汁作为头煎;将药渣重复上述步骤煎煮,煮好后,将两次煎煮的药汁合并即可;2)外用药按实施例2中的重量份称取中药原料重复进行步骤一,取出药液倒入泡脚盆中,向泡脚盆内加入温度为45℃的热水,脚伸入泡脚盆中浸泡15分钟即可。
实施例6:
一种制备护理治疗胆管细胞癌的中药配方的方法,由以下步骤组成:1)内服药按实施例3中的重量份称取中药原料,加入冷水,没过药材5cm,浸泡1个小时;然后进行煎煮,先用武火煮开,煮开后转为文火熬煮38min;煮好后,滤出药汁作为头煎;将药渣重复上述步骤煎煮,煮好后,将两次煎煮的药汁合并即可;2)外用药按实施例3中的重量份称取中药原料重复进行步骤一,取出药液倒入泡脚盆中,向泡脚盆内加入温度为40℃的热水,脚伸入泡脚盆中浸泡20分钟即可。
以上已将本发明做一详细说明,以上所述,仅为本发明之较佳实施例而已,当不能限定本发明实施范围,即凡依本申请范围所作均等变化与修饰,皆应仍属本发明涵盖范围内。
Claims (4)
1.一种护理治疗胆管细胞癌的中药配方,其特征在于由内服药和外用药组成,其中内服药由以下重量份数的中药原料配制而成:人参10-15份,青黛5-8份,牛黄2-4份,菊花2-4份,柴胡10-15份,蚤休10-15份,茯苓10-15份,赤芍4-10份,茜草10-15份,当归10-15份,黄芩2-4份,莪术10-15份,瓜蒌10-15份,鳖甲3-8份,虎杖3-8份;
其中外用药由以下重量份数的中药原料配制而成:败酱草5-8份,山慈菇3-5份,五倍子10-15份,红大戟15-20份,穿心莲3-5份,千金子10-15份,三七5-10份,冰片5-10份,丁香罗勒6-10份,陈皮10-15份。
2.根据权利要求1所述的一种护理治疗胆管细胞癌的中药配方,其特征在于:内服药为由以下重量份数的中药原料配制而成:人参13份,青黛6份,牛黄3份,菊花3份,柴胡13份,蚤休12份,茯苓13份,赤芍6份,茜草12份,当归12份,黄芩3份,莪术13份,瓜蒌13份,鳖甲6份,虎杖6份。
3.根据权利要求1所述的一种护理治疗胆管细胞癌的中药配方,其特征在于:外用药为由以下重量份数的中药原料配制而成:败酱草6份,山慈菇4份,五倍子12份,红大戟17份,穿心莲4份,千金子14份,三七6份,冰片7份,丁香罗勒8份,陈皮14份。
4.一种制备如权利要求1所述的护理治疗胆管细胞癌的中药配方的方法,其特征在于:由以下步骤组成:1)内服药按上述重量份称取中药原料,加入冷水,没过药材4-6cm,浸泡1个小时;然后进行煎煮,先用武火煮开,煮开后转为文火熬煮35-40min;煮好后,滤出药汁作为头煎;将药渣重复上述步骤煎煮,煮好后,将两次煎煮的药汁合并即可;2)外用药按上述重量份称取中药原料重复进行步骤一,取出药液倒入泡脚盆中,向泡脚盆内加入温度为35-45℃的热水,脚伸入泡脚盆中浸泡15-20分钟即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410768436.5A CN104436060A (zh) | 2014-12-11 | 2014-12-11 | 一种护理治疗胆管细胞癌的中药配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410768436.5A CN104436060A (zh) | 2014-12-11 | 2014-12-11 | 一种护理治疗胆管细胞癌的中药配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104436060A true CN104436060A (zh) | 2015-03-25 |
Family
ID=52883321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410768436.5A Pending CN104436060A (zh) | 2014-12-11 | 2014-12-11 | 一种护理治疗胆管细胞癌的中药配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104436060A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412881A (zh) * | 2015-12-22 | 2016-03-23 | 曲德春 | 一种泡脚汤配方及制备方法 |
-
2014
- 2014-12-11 CN CN201410768436.5A patent/CN104436060A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412881A (zh) * | 2015-12-22 | 2016-03-23 | 曲德春 | 一种泡脚汤配方及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520654B (zh) | 一种用于治疗膝骨关节炎的中药组合物及其制备方法 | |
CN103463356B (zh) | 治疗阳虚痹症的中药组合物 | |
CN104758852A (zh) | 一种治疗高血压的中药组合物 | |
CN104399009A (zh) | 治疗肝癌的中药配方及其制备方法 | |
CN103211930A (zh) | 一种降血脂、降血压的中药制剂 | |
CN104491831A (zh) | 一种治疗致密性骶髂骨关节炎的中药制剂及其制备方法 | |
CN103495055A (zh) | 一种用于治疗女性内分泌失调的中药汤剂及制备方法 | |
CN103893670B (zh) | 一种治疗心脑血管病的中药药丸 | |
CN107137499A (zh) | 一种调理身体补充元气的热敷粉包 | |
CN102579818B (zh) | 一种藏药组合物及其制备方法与应用 | |
CN103736003A (zh) | 一种治疗乳腺增生的药物 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN105727163A (zh) | 一种治疗肝癌的中药配方及其制备方法 | |
CN105727001A (zh) | 一种治疗心脑血管疾病的中药组合物 | |
CN104436060A (zh) | 一种护理治疗胆管细胞癌的中药配方及其制备方法 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
CN105688075A (zh) | 一种治疗腹痛的新型口服制剂及其制备方法 | |
CN112263663A (zh) | 一种用于治疗阳虚体质相关妇科疾病的中药组合物 | |
CN104547402A (zh) | 一种治疗气滞血瘀型痛经的足浴药液 | |
CN104740193A (zh) | 一种治疗颈肩肌肉劳损综合症的中药组合物及其制备方法 | |
CN104689109A (zh) | 治疗高血压的中药汤剂 | |
CN105727165A (zh) | 一种治疗肝癌的中药配方及其制备方法 | |
CN104306943A (zh) | 一种治疗高血脂症的中药组合物 | |
CN104288675A (zh) | 一种防治甲型肝炎的中药配方及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |